Best Cryotherapy for kidney cancer Doctors Worldwide — TOP 23

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Leading expert in cryotherapy for kidney cancer with over 41 years of experience of experience at Sourasky Medical Center.

• Specializes in soft tissue and bone oncology
• Fellowship in sarcoma treatment at Institut Gustave Roussy, Paris
• Member of ESMO Sarcoma Faculty Group
• Published extensive research on oncology treatments

Dr. Sarid specializes in kidney cancer cryotherapy with training from Oxford University in cancer urology. He's a senior oncologist at Sourasky Medical Center.

• Over 38 years of experience' experience in oncology
• Author of 30+ articles on cancer treatment
• Principal investigator in clinical trials for new cancer therapies
• Lecturer at Tel Aviv University
• Member of European and American oncology societies

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Dr. Solak trained in oncology at Hacettepe University Cancer Institute – a leading cancer center – and MD Anderson Cancer Center.

• Specialized in kidney, breast, and gastrointestinal cancers
• Experience treating complex cases at multiple hospitals
• Education includes Turkey's top medical schools

Dr. Dror Levin is a senior pediatrician specializing in children's hematology oncology at Sourasky Medical Center.

• Directs the children's hematology oncology department
• Coordinates treatment for bone cancer and soft tissue sarcoma in children
• Member of ISPHO – Israel's pediatric hemato-oncology association
• Trained at leading institutions including Rizzoli Orthopaedic Institute in Italy

Professor of Medical Oncology with over 29 years of experience of experience – Dr. Saglam specializes in gastrointestinal oncology at Gayrettepe Florence Nightingale Hospital.

• Fellowship-trained at Istanbul University Oncology Institute
• Member of ESMO, ASCO, and European Neuroendocrine Tumour Society
• Skilled in advanced cryotherapy techniques for kidney cancer

Specializes in cryotherapy for kidney cancer at Medical Park Antalya Hospital Complex, with a strong background in medical oncology.

• 20 years of experience of medical experience with 20 years of experience focused on oncology
• Trained at Akdeniz University, known for its oncology program
• Works in a leading hospital complex with advanced cancer treatment facilities
• Skilled in multiple aspects of cancer treatment and patient care

Dr. Shruti Kate specializes in advanced cancer treatments, including cryotherapy for kidney cancer, at HCG Manavata Cancer Centre.

• Trained at Tata Memorial Hospital – India's premier cancer center
• Expertise in lung, breast, and genitourinary cancers
• Member of ASCO, ESMO, and other leading oncology societies
• Presented research at World Conference on Lung Cancer

Dr. Chaitainya Borde has performed over 30,000 PET scans and treated 1,000+ thyroid cancer patients at HCG Manavata Cancer Centre.

• 11 years of experience of experience in nuclear medicine
• Expert in radioiodine and Lu-177 RN therapies
• Published researcher in medical journals

Dr. Sridhar P.S. specializes in radiotherapy with extensive training from Banaras Hindu University and National Board Of Examination.

• Board-certified in radiotherapy with over 30 years of experience of experience
• Member of the Association of Radiation Oncology of India
• Active in the Bangalore Oncology Group
• Specializes in hyperthermia oncology

Dr. Ahmer Arif Shaikh specializes in surgical oncology with expertise in head and neck surgeries at HCG Manavata Cancer Centre.

• 15 years of experience of experience in surgical oncology
• Fellowship-trained in Head & Neck Surgical Oncology
• Proficient in major maxillofacial and head & neck surgeries
• Focuses on organ preservation and functional rehabilitation

Dr. Banswal specializes in minimally invasive cancer surgeries, performing over 10,000 major surgeries with excellent outcomes at HCG Manavata Cancer Centre.

• 15 years of experience of surgical oncology experience
• Fellowship-trained in gastrointestinal cancer at Tata Medical Center
• Co-principal investigator in multiple research studies
• Expert in patient-friendly, ethical approaches

Prof. Dr. Abdullah Sakin is a professor of medical oncology. He treats solid tumors, including lung, breast, gastrointestinal, genitourinary, gynecologic, head and neck cancers, and melanoma.

He delivers personalized, evidence-based care. His treatments include chemotherapy, targeted therapy, immunotherapy, hormone therapy, and precision oncology. He has authored more than 200 scientific publications and takes part in international clinical research. This work advances patient-centered cancer care.

Dr. Shaunak specializes in targeted therapies for kidney cancer, with a strong focus on molecular oncology research.

• Completed DNB in Medical Oncology from Indraprastha Apollo Hospital
• Presented research on stomach cancer at ASCO symposium
• Expertise in molecular basis of cancer
• Senior Residency in Internal Medicine